Expanded Applications of Photobiomodulation Therapy

Publication ID: 24-11857800_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Expanded Applications of Photobiomodulation Therapy,” Published Technical Disclosure No. 24-11857800_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857800_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,800.

Summary of the Inventive Concept

The inventive concept disclosed herein leverages the core technology of photobiomodulation therapy to address novel applications and use cases across various industries, including athletic performance, sleep disorders, agriculture, veterinary care, and stress reduction.

Background and Problem Solved

The original patent application primarily focused on treating disorders using photobiomodulation therapy with near-infrared light. However, the limitations of this approach lie in its narrow scope, failing to explore the vast potential of this technology in other fields. The inventive concept addresses this limitation by applying the core technology to entirely new industries, solving problems such as muscle fatigue, sleep disorders, crop yields, animal injuries, and stress management.

Detailed Description of the Inventive Concept

The new inventive concept involves adapting the photobiomodulation therapy technology to administer near-infrared light in various settings, including wearable garments for athletes, sleep disorder patients, and agricultural applications, as well as veterinary devices for treating animal injuries. The system comprises wearable or portable devices that emit near-infrared light at specific wavelengths and durations tailored to the specific application. In athletic performance, the device enhances muscle recovery and reduces fatigue. For sleep disorders, the device regulates the body's circadian rhythms. In agriculture, the device enhances photosynthesis and increases crop yields. In veterinary care, the device treats musculoskeletal injuries in animals. Finally, for stress reduction, the device stimulates relaxation and calmness.

Novelty and Inventive Step

The novelty of this inventive concept lies in its expansion of the photobiomodulation therapy technology to new, unrelated industries, solving problems that were not originally considered. The inventive step involves the adaptation of the core technology to address specific challenges in each of these new fields, resulting in a non-obvious and innovative solution.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include stationary devices for use in clinics or hospitals, implantable devices for long-term treatment, or even handheld devices for personal use. Variations could also involve different wavelengths or durations of near-infrared light, tailored to specific applications or user needs.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential across various industries, including sports medicine, healthcare, agriculture, veterinary care, and wellness. The target market includes professional athletes, individuals suffering from sleep disorders, farmers and agricultural companies, veterinarians, and individuals seeking stress reduction solutions. The potential market size is substantial, with opportunities for partnerships, licensing, and direct sales.

Field of Art

Biomedical engineering and photobiomodulation therapy, with expertise in wearable medical devices, light-based therapeutic technologies, and biomechanical applications across multiple domains

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degree in biomedical engineering, bioengineering, or related field, possessing knowledge of photobiomodulation principles, light wavelength interactions with biological systems, and experience designing therapeutic wearable technologies

Obviousness Rationale

A PHOSITA would recognize that the fundamental photobiomodulation mechanism disclosed in US 11857800 can be systematically adapted across different biological systems by modulating light parameters. The core technology of near-infrared light administration for cellular stimulation represents a generalizable therapeutic approach that can be predictably extended to various physiological contexts. The variations in the PTD represent logical extrapolations of the source patent's core technological principles, utilizing known photobiomodulation mechanisms to address related therapeutic challenges.

Obvious Combinations & Variations

Source Patent Element
Headband with near-infrared light emitting diodes configured for targeted photobiomodulation
PTD Variation
Expanding device design to wearable garments for athletes, veterinary applications, and agricultural use
Obviousness Reasoning
Predictable extension of existing wearable light therapy technology to new biological contexts, representing a straightforward design adaptation with expected therapeutic outcomes
Source Patent Element
Near-infrared light calibrated between 50-300 mW/cm2 irradiance
PTD Variation
Modifying light parameters for specific biological targets like muscle recovery, circadian rhythm regulation, and stress reduction
Obviousness Reasoning
Known technique of adjusting light wavelength and intensity to achieve specific physiological responses, representing a routine optimization process for a skilled practitioner
Source Patent Element
Sensor-enabled photobiomodulation device for monitoring treatment parameters
PTD Variation
Implementing sensor technologies across diverse application domains like agriculture, veterinary care, and athletic performance
Obviousness Reasoning
Obvious application of existing monitoring technologies to expand therapeutic tracking capabilities across different biological systems
Source Patent Element
Wearable near-infrared light therapy device for human applications
PTD Variation
Extending device design to non-human biological systems including plants and animals
Obviousness Reasoning
Predictable technological transfer representing a logical progression of photobiomodulation principles across different organic systems
35 U.S.C. § 103 Summary: Based on the teachings of US 11857800, a person having ordinary skill in the art would find the variations disclosed in the Published Technical Disclosure to represent obvious extensions of existing photobiomodulation therapy technologies. The systematic adaptation of near-infrared light therapeutic principles across diverse biological contexts constitutes prima facie obviousness under 35 U.S.C. ยง 103, rendering potential patent claims in these domains anticipated by the combination of prior art references.

Original Patent Information

Patent NumberUS 11,857,800
TitlePhotobiomodulation therapy garment, methods and uses
Assignee(s)Niraxx, Inc.